ATE199057T1 - Neue verwendung von diphenylbutyl- piperazincarboxamiden zur behandlung von störungen im zusammenhang mit der verwendung giftiger stoffen - Google Patents

Neue verwendung von diphenylbutyl- piperazincarboxamiden zur behandlung von störungen im zusammenhang mit der verwendung giftiger stoffen

Info

Publication number
ATE199057T1
ATE199057T1 AT92907159T AT92907159T ATE199057T1 AT E199057 T1 ATE199057 T1 AT E199057T1 AT 92907159 T AT92907159 T AT 92907159T AT 92907159 T AT92907159 T AT 92907159T AT E199057 T1 ATE199057 T1 AT E199057T1
Authority
AT
Austria
Prior art keywords
diphenylbutyl
treatment
toxic substances
disorders related
piperazine
Prior art date
Application number
AT92907159T
Other languages
English (en)
Inventor
Anders Bjoerk
Erik Christensson
Original Assignee
Pharmacia & Upjohn Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab
Application granted granted Critical
Publication of ATE199057T1 publication Critical patent/ATE199057T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
AT92907159T 1991-03-22 1992-03-23 Neue verwendung von diphenylbutyl- piperazincarboxamiden zur behandlung von störungen im zusammenhang mit der verwendung giftiger stoffen ATE199057T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9100860A SE9100860D0 (sv) 1991-03-22 1991-03-22 New use
PCT/SE1992/000182 WO1992016211A1 (en) 1991-03-22 1992-03-23 New use of diphenylbutyl-piperazinecarboxamides in the treatment of substance disorders

Publications (1)

Publication Number Publication Date
ATE199057T1 true ATE199057T1 (de) 2001-02-15

Family

ID=20382242

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92907159T ATE199057T1 (de) 1991-03-22 1992-03-23 Neue verwendung von diphenylbutyl- piperazincarboxamiden zur behandlung von störungen im zusammenhang mit der verwendung giftiger stoffen

Country Status (24)

Country Link
US (2) US5434156A (de)
EP (1) EP0538422B1 (de)
JP (1) JP3221611B2 (de)
KR (1) KR100196674B1 (de)
AT (1) ATE199057T1 (de)
AU (1) AU653797B2 (de)
BG (1) BG61829B1 (de)
BR (1) BR9204969A (de)
CA (1) CA2083505C (de)
CZ (1) CZ282222B6 (de)
DE (1) DE69231680T2 (de)
DK (1) DK0538422T3 (de)
EE (1) EE02973B1 (de)
ES (1) ES2154261T3 (de)
GR (1) GR3035805T3 (de)
HU (2) HU217833B (de)
IE (1) IE920920A1 (de)
NO (1) NO301311B1 (de)
PT (1) PT100279B (de)
RO (1) RO109702B1 (de)
RU (1) RU2095062C1 (de)
SE (1) SE9100860D0 (de)
SK (1) SK279237B6 (de)
WO (1) WO1992016211A1 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9100860D0 (sv) * 1991-03-22 1991-03-22 Kabi Pharmacia Ab New use
SE9201239D0 (sv) 1992-04-21 1992-04-21 Kabi Pharmacia Ab Agents for treating substance abuse disorders
JP3571114B2 (ja) * 1995-07-11 2004-09-29 ポーラ化成工業株式会社 麻薬拮抗剤
US6265393B1 (en) 1998-08-07 2001-07-24 Heinrichs William Leroy Prevention of endometriosis signs or symptons
US6090780A (en) * 1999-04-07 2000-07-18 Chandon Prasad Histidyl-proline diketopiperazine and method of use
GB9923748D0 (en) 1999-10-07 1999-12-08 Glaxo Group Ltd Chemical compounds
USRE39921E1 (en) 1999-10-07 2007-11-13 Smithkline Beecham Corporation Chemical compounds
GB0025354D0 (en) 2000-10-17 2000-11-29 Glaxo Group Ltd Chemical compounds
US20050192271A1 (en) * 2003-07-15 2005-09-01 Hythiam, Inc. Use of selective chloride channel modulators to treat alcohol and/or stimulant substance abuse
ATE338575T1 (de) * 2001-01-17 2006-09-15 Hythiam Inc Verwendung von flumazenil bei der entwicklung eines arzneimittels zur behandlung von alkoholabhängigkeit
ES2287255T3 (es) * 2001-02-15 2007-12-16 Hythiam, Inc. Uso de flumazenil para producir un medicamento parta el tratamiento de la dependencia a cocaina.
US7183410B2 (en) * 2001-08-02 2007-02-27 Bidachem S.P.A. Stable polymorph of flibanserin
US20030060475A1 (en) * 2001-08-10 2003-03-27 Boehringer Ingelheim Pharma Kg Method of using flibanserin for neuroprotection
UA78974C2 (en) * 2001-10-20 2007-05-10 Boehringer Ingelheim Pharma Use of flibanserin for treating disorders of sexual desire
US10675280B2 (en) 2001-10-20 2020-06-09 Sprout Pharmaceuticals, Inc. Treating sexual desire disorders with flibanserin
GB0203020D0 (en) 2002-02-08 2002-03-27 Glaxo Group Ltd Chemical compounds
JP2005522436A (ja) 2002-02-08 2005-07-28 グラクソ　グループ　リミテッド ピペリジルカルボキシアミド誘導体またはそのタキキニン介在疾患の治療における使用
GB0203022D0 (en) 2002-02-08 2002-03-27 Glaxo Group Ltd Chemical compounds
US20050239798A1 (en) * 2004-04-22 2005-10-27 Boehringer Ingelheim Pharmaceuticals, Inc. Method for the treatment of premenstrual and other female sexual disorders
CA2563743A1 (en) * 2004-04-22 2005-11-03 Boehringer Ingelheim International Gmbh New pharmaceutical compositions for the treatment of sexual disorders ii
US20060025420A1 (en) * 2004-07-30 2006-02-02 Boehringer Ingelheimn International GmbH Pharmaceutical compositions for the treatment of female sexual disorders
WO2006024471A1 (en) * 2004-09-03 2006-03-09 Boehringer Ingelheim International Gmbh Method for the treatment of attention deficit hyperactivity disorder
JP2008531714A (ja) * 2005-03-04 2008-08-14 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 不安障害の治療用及び／又は予防用の医薬組成物
WO2006096439A2 (en) * 2005-03-04 2006-09-14 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases
WO2006096435A1 (en) * 2005-03-04 2006-09-14 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for the treatment and/or prevention of depression
WO2006119884A2 (en) * 2005-05-06 2006-11-16 Boehringer Ingelheim International Gmbh Method for the treatment of drug abuse with flibanserin
US20060264512A1 (en) * 2005-05-19 2006-11-23 Boehringer Ingelheim International Gmbh Method for the treatment of sexual dysfunction due to medical conditions
JP2008540673A (ja) * 2005-05-19 2008-11-20 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 薬剤誘発性性機能不全の治療方法
ES2646326T3 (es) 2005-08-03 2017-12-13 Sprout Pharmaceuticals, Inc. Uso de flibanserina en el tratamiento de la obesidad
US20070123540A1 (en) * 2005-10-29 2007-05-31 Angelo Ceci Sexual desire enhancing medicaments comprising benzimidazolone derivatives
WO2007048803A1 (en) * 2005-10-29 2007-05-03 Boehringer Ingelheim International Gmbh Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders
US20070105869A1 (en) * 2005-11-08 2007-05-10 Stephane Pollentier Use of flibanserin for the treatment of pre-menopausal sexual desire disorders
BRPI0712039A2 (pt) * 2006-05-09 2011-12-20 Boehringer Ingelheim Int uso de flibanserina para o tratamento de distúrbios de desejo sexual pós-menopausa
WO2008000760A1 (en) 2006-06-30 2008-01-03 Boehringer Ingelheim International Gmbh Flibanserin for the treatment of urinary incontinence and related diseases
EP2043648A1 (de) * 2006-07-14 2009-04-08 Boehringer Ingelheim International GmbH Verwendung von flibanserin zur behandlung von sexualstörungen bei frauen
CL2007002214A1 (es) * 2006-08-14 2008-03-07 Boehringer Ingelheim Int Composicion farmaceutica en la forma de comprimido, donde al menos la longitud del comprimido en el estado anterior de la aplicacion es al menos 7/12 del diametro pilorico del paciente y despues de ingerirlo en estado alimentado, la longitud del comp
BRPI0716439B8 (pt) 2006-08-14 2021-05-25 Boehringer Ingelheim Int sistemas de liberação farmacêutico compreendendo flibanserina, processo para preparação e uso dos mesmos
BRPI0716436B8 (pt) * 2006-08-25 2021-05-25 Boehringer Ingelheim Int sistema de liberação controlada e método para fabricação do mesmo
CL2008002693A1 (es) 2007-09-12 2009-10-16 Boehringer Ingelheim Int Uso de flibanserina para el tratamiento de sintomas vasomotores seleccionados de sofocos, sudores nocturnos, cambios de estado de animo e irritabilidad

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO154582C (no) * 1978-10-20 1986-11-05 Ferrosan Ab Analogifremgangsmaate for fremstilling av terapeutisk aktive difenyl-dibutylpiperazinkarboksamider.
SE9100860D0 (sv) * 1991-03-22 1991-03-22 Kabi Pharmacia Ab New use

Also Published As

Publication number Publication date
HU9203632D0 (en) 1993-03-29
JPH05507731A (ja) 1993-11-04
NO301311B1 (no) 1997-10-13
PT100279A (pt) 1993-07-30
SK279237B6 (sk) 1998-08-05
CA2083505C (en) 2003-06-10
JP3221611B2 (ja) 2001-10-22
NO924502L (no) 1992-11-23
SK344992A3 (en) 1995-11-08
SE9100860D0 (sv) 1991-03-22
KR100196674B1 (ko) 1999-06-15
BG97108A (bg) 1994-03-24
NO924502D0 (no) 1992-11-23
DK0538422T3 (da) 2001-05-07
BG61829B1 (bg) 1998-07-31
RU2095062C1 (ru) 1997-11-10
US5618817A (en) 1997-04-08
EP0538422B1 (de) 2001-02-07
WO1992016211A1 (en) 1992-10-01
RO109702B1 (ro) 1995-05-30
KR930700108A (ko) 1993-03-13
GR3035805T3 (en) 2001-07-31
PT100279B (pt) 1999-06-30
CZ282222B6 (cs) 1997-06-11
CA2083505A1 (en) 1992-09-23
AU1428092A (en) 1992-10-21
IE920920A1 (en) 1992-09-23
CZ344992A3 (en) 1994-02-16
ES2154261T3 (es) 2001-04-01
AU653797B2 (en) 1994-10-13
DE69231680T2 (de) 2001-06-07
BR9204969A (pt) 1993-07-27
DE69231680D1 (de) 2001-03-15
HUT64696A (en) 1994-02-28
EP0538422A1 (de) 1993-04-28
EE02973B1 (et) 1997-04-15
HU217833B (hu) 2000-04-28
US5434156A (en) 1995-07-18

Similar Documents

Publication Publication Date Title
DE69231680D1 (de) Neue verwendung von diphenylbutyl-piperazincarboxamiden zur behandlung von störungen im zusammenhang mit der verwendung giftiger stoffen
ATE188341T1 (de) Konservierungsmittel und verfahren zur behandlung von holz
DE69431601D1 (de) Neue verwendung von dexmedetomidin
IL113566A0 (en) Use of certain methanebisphosphonic acid derivatives to prevent prosthesis loosening and prosthesis migration
RU92016400A (ru) Применение дифенилбутил-пиперазинкарбоксамидов при лечении токсикоманий
KR100321319B1 (ko) 물질남용장애를치료하는방법및제약학적조성물
ATE281162T1 (de) Verwendung von gingko biloba extrakten zur herstellung eines arzneimittels zur behandlung der amyotrophen lateralsklerose
SG49239A1 (en) Amylin and possibly insulin containing composition for the treatment of aneroxia and related states
ATE190484T1 (de) Arzneimittel zur behandlung von durch babesia verursachten protozoeninfektionen
ATE122889T1 (de) Verwendung von mizoribin zur behandlung oder vorbeugung der multiplen sklerose.
KR930001908A (ko) 당뇨병에 있어서의 1,4-디히드로피리딘의 용도
ATE245432T1 (de) Verwendung von extrakten aus ginkgo-biloba- blättern zur behandlung von schlafstörungen
ATE232085T1 (de) Behandlung von koronaren störungen durch arzneimittelabgabe im herzbeutel
ATE103491T1 (de) Behandlung von arteriosklerosis durch verabreichung von l-tryptophane oder l-5hydroxytryptophan.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee